Literature DB >> 29594055

Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.

Elena Sabini1, Ilaria Ionni1, Roberto Rocchi1, Paolo Vitti1, Claudio Marcocci1, Michele Marinò1.   

Abstract

BACKGROUND: Graves' orbitopathy (GO) is believed to be the consequence of autoimmunity against antigens that are present both in the thyroid and orbital tissues. Massive release of thyroid antigens causes the appearance or deterioration of GO in patients with Graves' hyperthyroidism (GH), as it occurs following radioiodine treatment. In theory, a similar release of autoantigens may occur at the eye level, for example due to an orbital trauma or surgical manipulation. To our knowledge, this is the first report of a case of de novo appearance of GO and then GH after an eye trauma, possibly reflecting spreading of autoantigens and activation of the immune system against shared orbital and thyroid antigens. CASE REPORT: An otherwise healthy, 57-year-old man presented 6 months after the appearance of a monolateral right orbitopathy, which occurred 40 days after a trauma in the ipsilateral eye. His thyroid function was normal, with positive serum anti-TSH receptor autoantibodies. The thyroid was normal on ultrasound. A month later he developed hyperthyroidism and orbitopathy in the left eye. DISCUSSION: The development of GO after an eye trauma may reflect tissue damage with release of autoantigens and consequent autoimmunity in a predisposed individual (our patient had a familial history of autoimmune thyroid disease). The subsequent development of hyperthyroidism is in keeping with the hypothesis that GH and GO are due to autoimmunity against antigens present both in the thyroid and in orbital tissues.

Entities:  

Keywords:  Autoimmunity; Graves' disease; Graves' orbitopathy; Thyroid

Year:  2017        PMID: 29594055      PMCID: PMC5836176          DOI: 10.1159/000479629

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  22 in total

1.  Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study.

Authors:  M P Mourits; S H C Lombardo; F A van der Sluijs; S Fenton
Journal:  Orbit       Date:  2004-09

2.  Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.

Authors:  L Bartalena; C Marcocci; F Bogazzi; M Panicucci; A Lepri; A Pinchera
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

3.  Ophthalmopathy and thyroid stimulation.

Authors:  F Karlsson; K Westermark; P A Dahlberg; R Jansson; P Enoksson
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

Review 4.  Total thyroid ablation in Graves' orbitopathy.

Authors:  F Menconi; M Leo; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

5.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; M P Mourits; L Koornneef; A Berghout; R van der Gaag
Journal:  Arch Intern Med       Date:  1990-05

6.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; F Bogazzi; L Manetti; M L Tanda; E Dell'Unto; G Bruno-Bossio; M Nardi; M P Bartolomei; A Lepri; G Rossi; E Martino; A Pinchera
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

7.  Severe Graves' ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease.

Authors:  Daniel Chun-Hang Wai; Su-Chin Ho; Lay-Leng Seah; Kee-Siew Fong; Daphne Hsu-Chin Khoo
Journal:  Thyroid       Date:  2003-08       Impact factor: 6.568

8.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

9.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

Authors:  L Tallstedt; G Lundell; O Tørring; G Wallin; J G Ljunggren; H Blomgren; A Taube
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

10.  Reactivation of thyroid associated orbitopathy following trauma with intraorbital foreign body.

Authors:  Thanos D Papakostas; Nahyoung Grace Lee; Alison B Callahan; Suzanne K Freitag
Journal:  Orbit       Date:  2014-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.